Cancer Gene Therapy Market Growth Opportunities and Forecast till 2032
CHAPTER 1. Industry Overview of Cancer Gene Therapy Market
1.1. Definition and Scope
1.1.1. Definition of Cancer Gene Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cancer Gene Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cancer Gene Therapy Market By Therapy
1.2.3. Cancer Gene Therapy Market By End Use
1.2.4. Cancer Gene Therapy Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-Use
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Gene Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cancer Gene Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Cancer Gene Therapy Market By Therapy
4.1. Introduction
4.2. Cancer Gene Therapy Revenue By Therapy
4.2.1. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast, By Therapy, 2020-2032
4.2.2. Gene Induced Immunotherapy
4.2.2.1. Gene-Induced Immunotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Oncolytic Virotherapy
4.2.3.1. Oncolytic Virotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. Gene Transfer
4.2.4.1. Gene Transfer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Cancer Gene Therapy Market By End Use
5.1. Introduction
5.2. Cancer Gene Therapy Revenue By End Use
5.2.1. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast, By End Use, 2020-2032
5.2.2. Research Institutes
5.2.2.1. Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Biopharmaceutical Companies
5.2.3.1. Biopharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Diagnostic Centers
5.2.4.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. North America Cancer Gene Therapy Market By Country
6.1. North America Cancer Gene Therapy Market Overview
6.2. U.S.
6.2.1. U.S. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
6.2.2. U.S. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
6.3. Canada
6.3.1. Canada Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
6.3.2. Canada Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
6.4. North America PEST Analysis
CHAPTER 7. Europe Cancer Gene Therapy Market By Country
7.1. Europe Cancer Gene Therapy Market Overview
7.2. U.K.
7.2.1. U.K. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
7.2.2. U.K. Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
7.3. Germany
7.3.1. Germany Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
7.3.2. Germany Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
7.4. France
7.4.1. France Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
7.4.2. France Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
7.5. Spain
7.5.1. Spain Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
7.5.2. Spain Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
7.6. Rest of Europe
7.6.1. Rest of Europe Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
7.6.2. Rest of Europe Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
CHAPTER 8. Asia Pacific Cancer Gene Therapy Market By Country
8.1. Asia Pacific Cancer Gene Therapy Market Overview
8.2. China
8.2.1. China Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.2.2. China Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.3. Japan
8.3.1. Japan Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.3.2. Japan Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.4. India
8.4.1. India Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.4.2. India Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.5. Australia
8.5.1. Australia Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.5.2. Australia Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.6. South Korea
8.6.1. South Korea Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.6.2. South Korea Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
8.7.2. Rest of Asia-Pacific Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Cancer Gene Therapy Market By Country
9.1. Latin America Cancer Gene Therapy Market Overview
9.2. Brazil
9.2.1. Brazil Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.2.2. Brazil Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
9.3. Mexico
9.3.1. Mexico Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.3.2. Mexico Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
9.4. Rest of Latin America
9.4.1. Rest of Latin America Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
9.4.2. Rest of Latin America Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Cancer Gene Therapy Market By Country
10.1. Middle East & Africa Cancer Gene Therapy Market Overview
10.2. GCC
10.2.1. GCC Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.2.2. GCC Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
10.3. South Africa
10.3.1. South Africa Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.3.2. South Africa Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By Therapy, 2020-2032
10.4.2. Rest of Middle East & Africa Cancer Gene Therapy Market Revenue (USD Billion) and Forecast By End Use, 2020-2032
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Cancer Gene Therapy
11.1. Cancer Gene Therapy Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Cancer Gene Therapy Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. COMPANY PROFILE
12.1. Abeona Therapeutics Inc.
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Billion), 2023
12.1.3.2. Abeona Therapeutics Inc. 2023 Cancer Gene Therapy Business Regional Distribution
12.1.4. Product / Service and Specification
12.1.5. Recent Developments & Business Strategy
12.1.6. Manufacturing Plant Footprint Analysis
12.2. Altor Bioscience Inc.
12.3. Asklepios BioPharmaceutical Inc.
12.4. BioCancell Inc.
12.5. Bluebird bio Inc.
12.6. Celgene Inc.
12.7. Elevate Bio Inc.
12.8. GenVec
12.9. Genelux Corporation
12.10. GSK plc.
12.11. Introgen Therapeutics Inc.
12.12. Merck KGaA
12.13. OncoGenex Pharmaceuticals